"Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology*"[MeSH Major Topic] - Search Results

Year	Number of Results
1989	2
1990	45
1991	170
1992	151
1993	182
1994	157
1995	160
1996	149
1997	141
1998	113
1999	105
2000	88
2001	88
2002	92
2003	85
2004	73
2005	69
2006	68
2007	67
2008	54
2009	56
2010	46
2011	60
2012	42
2013	32
2014	56
2015	51
2016	43
2017	44
2018	32
2019	39
2020	39
2021	16
2022	28
2023	27
2024	6

1

Granulocyte-macrophage colony-stimulating factor promotes endometrial repair after injury by regulating macrophages in mice.

Zhu X, Chen S, Zhang P, Ma Y, Liu X, Fei H, Qian J, Hao Y, Jiang L, Lin X. Zhu X, et al. J Reprod Immunol. 2023 Dec;160:104156. doi: 10.1016/j.jri.2023.104156. Epub 2023 Sep 23. J Reprod Immunol. 2023. PMID: 37801891

2

Granulocyte-Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade.

Li X, Li J, Zheng Y, Lee SJ, Zhou J, Giobbie-Hurder A, Butterfield LH, Dranoff G, Hodi FS. Li X, et al. Cancer Immunol Res. 2023 Aug 3;11(8):1100-1113. doi: 10.1158/2326-6066.CIR-22-0702. Cancer Immunol Res. 2023. PMID: 37262321 Free PMC article.

3

Efficacy and safety of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in COVID-19 patients: a meta-analysis.

Xi AR, Luo YJ, Guan JT, Wang WJ, Xu ZH. Xi AR, et al. Inflammopharmacology. 2023 Feb;31(1):275-285. doi: 10.1007/s10787-022-01105-9. Epub 2022 Nov 29. Inflammopharmacology. 2023. PMID: 36445552 Free PMC article. Review.

4

Granulocyte-macrophage colony-stimulating factor-dependent CD11c-positive cells differentiate into active osteoclasts.

Ruef N, Dolder S, Aeberli D, Seitz M, Balani D, Hofstetter W. Ruef N, et al. Bone. 2017 Apr;97:267-277. doi: 10.1016/j.bone.2017.01.036. Epub 2017 Feb 1. Bone. 2017. PMID: 28161590

5

Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic Review.

Lally J, Malik S, Whiskey E, Taylor DM, Gaughran FP, Krivoy A, Flanagan RJ, Mijovic A, MacCabe JH. Lally J, et al. J Clin Psychopharmacol. 2017 Aug;37(4):441-446. doi: 10.1097/JCP.0000000000000715. J Clin Psychopharmacol. 2017. PMID: 28437295 Review.

6

Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities.

Mehta P, Porter JC, Manson JJ, Isaacs JD, Openshaw PJM, McInnes IB, Summers C, Chambers RC. Mehta P, et al. Lancet Respir Med. 2020 Aug;8(8):822-830. doi: 10.1016/S2213-2600(20)30267-8. Epub 2020 Jun 16. Lancet Respir Med. 2020. PMID: 32559419 Free PMC article. Review.

7

Practical Application of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Patients with Wounds.

Brem H, Howell R, Criscitelli T, Senderowicz A, Siegart N, Gorenstein S, Gillette B. Brem H, et al. Surg Technol Int. 2018 Jun 1;32:61-66. Surg Technol Int. 2018. PMID: 29611156 Review.

8

Granulocyte-macrophage colony-stimulating factor-stimulated human macrophages demonstrate enhanced functions contributing to T-cell activation.

Farzam-Kia N, Lemaître F, Carmena Moratalla A, Carpentier Solorio Y, Da Cal S, Jamann H, Klement W, Antel J, Duquette P, Girard JM, Prat A, Larochelle C, Arbour N. Farzam-Kia N, et al. Immunol Cell Biol. 2023 Jan;101(1):65-77. doi: 10.1111/imcb.12600. Epub 2022 Nov 5. Immunol Cell Biol. 2023. PMID: 36260372

9

CD4⁺ T cells produce GM-CSF and drive immune-mediated glomerular disease by licensing monocyte-derived cells to produce MMP12.

Paust HJ, Song N, De Feo D, Asada N, Tuzlak S, Zhao Y, Riedel JH, Hellmig M, Sivayoganathan A, Peters A, Kaffke A, Borchers A, Wenzel UO, Steinmetz OM, Tiegs G, Meister E, Mack M, Kurts C, von Vietinghoff S, Lindenmeyer MT, Hoxha E, Stahl RAK, Huber TB, Bonn S, Meyer-Schwesinger C, Wiech T, Turner JE, Becher B, Krebs CF, Panzer U. Paust HJ, et al. Sci Transl Med. 2023 Mar 15;15(687):eadd6137. doi: 10.1126/scitranslmed.add6137. Epub 2023 Mar 15. Sci Transl Med. 2023. PMID: 36921033

10

Systematic review of the use of granulocyte-macrophage colony-stimulating factor in patients with advanced melanoma.

Hoeller C, Michielin O, Ascierto PA, Szabo Z, Blank CU. Hoeller C, et al. Cancer Immunol Immunother. 2016 Sep;65(9):1015-34. doi: 10.1007/s00262-016-1860-3. Epub 2016 Jul 2. Cancer Immunol Immunother. 2016. PMID: 27372293 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

2,552 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

2,552 results

Results by year